SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-060021
Filing Date
2018-10-02
Accepted
2018-10-02 16:38:45
Documents
8
Period of Report
2018-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36169_18k.htm 8-K 47628
2 EX-10.1 a18-36169_1ex10d1.htm EX-10.1 1320937
3 EX-10.2 a18-36169_1ex10d2.htm EX-10.2 246706
4 EX-10.3 a18-36169_1ex10d3.htm EX-10.3 133341
5 EX-10.4 a18-36169_1ex10d4.htm EX-10.4 171031
6 EX-99.1 a18-36169_1ex99d1.htm EX-99.1 17976
7 GRAPHIC g361691ko01i001.gif GRAPHIC 1604
8 GRAPHIC g361691ki27ai001.gif GRAPHIC 1604
  Complete submission text file 0001104659-18-060021.txt   1943842
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 181101869
SIC: 2834 Pharmaceutical Preparations